5/7/2021  5:36:13 PM Chg. +1.14 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
85.44EUR +1.35% 1.46 mill.
Turnover: 124.64 mill.
85.01Bid Size: 13 85.47Ask Size: 140 107.11 bill.EUR 3.75% 8.70

Business description

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Management board & Supervisory board

Paul Hudson
Management board
Jean-Baptiste Chasseloup de Chatillon, Arnaud Robert, Bill Sibold, Dr. John Reed, Julie Van Ongevalle, Karen Linehan, Natalie Bickford, Olivier Charmeil, Philippe Luscan, Thomas Triomphe
Supervisory board
Serge Weinberg, Bernard Charles, Carole Piwnica, Christian Senectaire, Christophe Babule, Diane Souza, Fabienne Lecorvaisier, Gilles Schnepp, Laurent Attal, Lise Kingo, Marion Palme, Melanie Lee, Patrick Kron, Paul Hudson, Rachel Duan, Thomas Südhof

Company data

Name: Sanofi S.A.
Address: 54, Rue La Boétie,F-75008 Paris
Phone: +33-1-53-77-40-00
Fax: +33-1-53-77-43-03
E-mail: -
Internet: www.sanofi-aventis.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 88.70%
IPO date: -

Investor relations

Name: George Grofik
IR phone: +33-1-53-77-45-45
IR Fax: -
IR e-mail: investor.relations@sanofi.com

Company calendar

CW 31 | 7/29/2021 Interim Report 2nd Quarter/6 Months
CW 44 | 10/28/2021 Interim Report 3rd Quarter/9 Months

Main Shareholders